Extension du partenariat stratégique entre Paragon ID et Biolog-id pour la gestion et la traçabilité des produits de santé
Paragon ID is pleased to announce the extension of its collaboration with Biolog-id, the world leader in connected health solutions.
Paragon ID and Biolog-id have decided to extend their cooperation in order to consolidate their respective commercial strategies in the connected health market. This sector, in full expansion, will allow the two companies to establish their respective positions as leaders, internationally and in the long term.
Two major technological players in their sector
Biolog-id offers an innovative solution for the management and traceability of sensitive therapeutic products (red blood cell concentrates, platelets, plasma, chemotherapy preparations) based on Radio Frequency Identification (RFID) technology. This solution strengthens patient safety by guaranteeing that the right product is administered to the right patient. It also brings significant costs savings through the reduction of product losses and the optimisation of the supply chain (reduction of stock levels, remote management without manual intervention, etc.). In addition, it contributes to improving the working conditions of health personnel by relieving them of extremely time consuming administrative and logistical tasks.
Paragon ID is a leader in access control and traceability solutions and the leading manufacturer of RFID identification components in Europe. Relying on smart technologies such as RFID and NFC, Paragon ID has developed a comprehensive offering of solutions for the pharma and healthcare sector. The partnership with Biolog-id gives Paragon ID the opportunity to strengthen its position in the e-health market.
Pierre Parent, President, Biolog-id, says:« Biolog-id needed a strong partner like Paragon ID to support its international development. It is the ideal partner to produce our RFID tags with a very high level of performance: the quality of the products is exceptional, the punctuality is optimal and Paragon ID, because of its international locations, can accompany us in all the countries where we are present. Paragon ID is also a technology partner that is directly associated with our R & D efforts.»
Clem Garvey, Paragon ID's Chief Operating Officer adds:
« Biolog-id's growth ambitions are extremely important, like those of Paragon ID. The industrial strength of Paragon ID will help support Biolog-id in strategic geographical areas, particularly in North America, the world's leading health market, which represents for both our companies a target market filled with opportunities. »
This technological collaboration between the two companies is now supporting the development of Biolog-id in Europe, North America, the Middle East, Asia and Australia.
Founded in 2005, Biolog-id has developed a unique expertise in connected health solutions. Biolog-id has entered a phase of international expansion. In 2017, the company opened 2 sales subsidiaries (Spain, Italy) and, at the beginning of this year, created 3 other subsidiaries (India, Australia and the United States) which will become operational centers.
The strength of its solution and a portfolio of more than 100 patents filed in France and internationally make Biolog-id the number one player in the management and traceability of sensitive health products using RFID. The company is headquartered in Paris and its industrial facility is based in Bernay (Eure). It has nearly 80 employees and continues its recruitment plan in France and abroad to support its growth.
For more information, visit: www.biolog-id.fr.